Details about the neuroanatomical projections from CA1 to IA
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure |
Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|
| 88626 |
Field CA1 | Intercalated nuclei of the amygdala |
strong | biotinylated dextran amine (BDA) | Characteristically, CA1 fibers labeled with BDA accumulated densely in the intercalated nucleus (Fig. 4A–C). Collator note: dense labeling of the IA, especially caudally. Swanson Atlas Levels 26-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y.
, 2006 |
|---|
| 88683 |
Field CA1 | Intercalated nuclei of the amygdala |
moderate/strong | biotinylated dextran amine (BDA) | The intercalated nucleus displayed moderate-tointense labeling especially at rostral levels (Fig. 7A). Collator note: Swanson Atlas Levels 25-26. | Kishi T., Tsumori T., Yokota S. & Yasui Y.
, 2006 |
|---|
|
General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f |
Further details associated to record number 88683:
| Position of injection: ventro-caudal |
| Topological position of injection: is contained |
| Extension of injection outside: none |
| The injection was performed in: left hemisphere |
| | Position of terminal field: rostral |
| Topological position of terminal field: is contained |
| Extension of terminal field outside: none |
| The terminal field was found: ipsilateral |
| |
